Elicio Therapeutics (ELTX) Current Deferred Revenue (2020 - 2025)
Elicio Therapeutics (ELTX) posted Current Deferred Revenue of $680,000 for Q1 2025, up 8.5% from $627,000 a year earlier but down 41.8% from the prior quarter.
Powered by 
Analysis
Elicio Therapeutics (ELTX) Current Deferred Revenue (2020 - 2025) Analysis & Trends
At the end of FY2024, Elicio Therapeutics' Current Deferred Revenue came in at $1.17 million, up 68.4% from FY2023.
- Annual Current Deferred Revenue shows a four-year compound annual growth rate of -26.2% (FY2020 to FY2024).
- In prior years, Elicio Therapeutics' Current Deferred Revenue was $694,000 in FY2023 (-51.7%), $1.44 million in FY2022 (-37.6%), $2.3 million in FY2021 (-41.6%) and $3.94 million in FY2020.
- Quarterly Current Deferred Revenue has run from a low of $400,000 in Q2 2024 to a high of $5.18 million in Q2 2021 over five years.
- On a year-over-year basis, Current Deferred Revenue increased in two of the last four quarters, with growth averaging 0.9%.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $1.17 million (Q4 2024), $1.31 million (Q3 2024) and $400,000 (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn |
| 10 | Elicio Therapeutics | 30.98 Mn | -46.64 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 680,000.00 |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 400,000.00 |
| Mar 31, 2024 | 627,000.00 |
| Dec 31, 2023 | 694,000.00 |
| Sep 30, 2023 | 1.66 Mn |
| Dec 31, 2022 | 1.44 Mn |
| Mar 31, 2022 | 653,000.00 |
| Dec 31, 2021 | 2.30 Mn |
| Sep 30, 2021 | 3.66 Mn |
| Jun 30, 2021 | 5.18 Mn |
| Mar 31, 2021 | 3.79 Mn |
| Dec 31, 2020 | 3.94 Mn |
API Access
Elicio Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ELTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ELTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ELTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();